[1]
|
Patel, A.K. (2022) Introduction to Breast Screening and Diagnosis. Journal of the American College of Radiology, 19, 1079-1080.
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[3]
|
Burstein, M.D., Tsimelzon, A., Poage, G.M., et al. (2015) Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer. Clinical Cancer Research, 21, 1688-1698.
https://doi.org/10.1158/1078-0432.CCR-14-0432
|
[4]
|
Fang, S., Zhang, L., Guo, J., et al. (2018) NONCODEV5: A Comprehensive Annotation Database for Long Non-Coding RNAs. Nucleic Acids Research, 46, D308-D314. https://doi.org/10.1093/nar/gkx1107
|
[5]
|
Liang, W.Q., Zeng, D., Chen, C.F., et al. (2019) Long Noncoding RNA H19 Is a Critical Oncogenic Driver and Contributes to Epithelial-Mesenchymal Transition in Papillary Thyroid Carci-noma. Cancer Management and Research, 11, 2059-2072. https://doi.org/10.2147/CMAR.S195906
|
[6]
|
Cao, Y., Chai, W., Wang, Y., et al. (2021) lncRNA TUG1 Inhibits the Cancer Stem Cell-Like Properties of Temozolomide-Resistant Glioma Cells by Interacting with EZH2. Molecular Medicine Reports, 24, Article No. 533.
https://doi.org/10.3892/mmr.2021.12172
|
[7]
|
Pandey, M., Mukhopadhyay, A., Sharawat, S.K. and Kumar, S. (2021) Role of microRNAs in Regulating Cell Proliferation, Metastasis and Chemoresistance and Their Applications as Cancer Biomarkers in Small Cell Lung Cancer. Biochimica et Biophysica Acta—Reviews on Cancer, 1876, Article ID: 188552.
https://doi.org/10.1016/j.bbcan.2021.188552
|
[8]
|
Yin, X., Liao, Y., Xiong, W., Zhang, Y., Zhou, Y. and Yang, Y. (2020) Hypoxia-Induced lncRNA ANRIL Promotes Cisplatin Resistance in Retinoblastoma Cells through Regulating ABCG2 Expression. Clinical and Experimental Pharmacology and Physiology, 47, 1049-1057. https://doi.org/10.1111/1440-1681.13279
|
[9]
|
Chen, S., Zhang, J.Q., Chen, J.Z., et al. (2017) The Over Expres-sion of Long Non-Coding RNA ANRIL Promotes Epithelial-Mesenchymal Transition by Activating the ATM-E2F1 Signaling Pathway in Pancreatic Cancer: An in Vivo and in Vitro Study. International Journal of Biological Macro-molecules, 102, 718-728.
https://doi.org/10.1016/j.ijbiomac.2017.03.123
|
[10]
|
Chen, Y., Qin, H. and Zheng, L. (2022) Research Progress on RNA-Binding Proteins in Breast Cancer. Frontiers in Oncology, 12, Article ID: 974523. https://doi.org/10.3389/fonc.2022.974523
|
[11]
|
Porto, F.W., Daulatabad, S.V. and Janga, S.C. (2019) Long Non-Coding RNA Expression Levels Modulate Cell-Type-Specific Splicing Patterns by Altering Their Interaction Landscape with RNA-Binding Proteins. Genes (Basel), 10, Article No. 593. https://doi.org/10.3390/genes10080593
|
[12]
|
Lu, X., Zhong, J., Liu, L., et al. (2022) The Function and Regulatory Mechanism of RNA-Binding Proteins in Breast Cancer and Their Future Clinical Treatment Prospects. Frontiers in Oncology, 12, Article ID: 929037.
https://doi.org/10.3389/fonc.2022.929037
|
[13]
|
Zahler, A.M., Neugebauer, K.M., Stolk, J.A. and Roth, M.B. (1993) Human SR Proteins and Isolation of a cDNA Encoding SRp75. Molecular and Cellular Biology, 13, 4023-4028. https://doi.org/10.1128/MCB.13.7.4023
|
[14]
|
Anczuków, O., Rosenberg, A.Z., Akerman, M., et al. (2012) The Splicing Factor SRSF1 Regulates Apoptosis and Proliferation to Promote Mammary Epithelial Cell Transformation. Nature Structural & Molecular Biology, 19, 220-228.
https://doi.org/10.1038/nsmb.2207
|
[15]
|
Zhou, X., Li, X., Yu, L., et al. (2019) The RNA-Binding Protein SRSF1 Is a Key Cell Cycle Regulator via Stabilizing NEAT1 in Glioma. The International Journal of Biochemistry & Cell Biology, 113, 75-86.
https://doi.org/10.1016/j.biocel.2019.06.003
|
[16]
|
Brennan, C.M. and Steitz, J.A. (2001) HuR and mRNA Stability. Cellular and Molecular Life Sciences, 58, 266-277.
https://doi.org/10.1007/PL00000854
|
[17]
|
López de Silanes, I., Zhan, M., Lal, A., Yang, X. and Gorospe, M. (2004) Identification of a Target RNA Motif for RNA-Binding Protein HuR. Proceedings of the National Academy of Sciences of the United States of America, 101, 2987-2992. https://doi.org/10.1073/pnas.0306453101
|
[18]
|
Doller, A., Pfeilschifter, J. and Eberhardt, W. (2008) Signalling Pathways Regulating Nucleo-Cytoplasmic Shuttling of the mRNA-Binding Protein HuR. Cellular Signalling, 20, 2165-2173. https://doi.org/10.1016/j.cellsig.2008.05.007
|
[19]
|
Li, Y., Yu, J., Du, D., et al. (2013) Involvement of Post-Transcriptional Regulation of FOXO1 by HuR in 5-FU-Induced Apoptosis in Breast Cancer Cells. Oncology Letters, 6, 156-160. https://doi.org/10.3892/ol.2013.1352
|
[20]
|
Scott, G.K., Marx, C., Berger, C.E., et al. (2008) Destabilization of ERBB2 Transcripts by Targeting 3' Untranslated Region Messenger RNA Associated HuR and Histone Deacetylase-6. Molecular Cancer Research, 6, 1250-1258.
https://doi.org/10.1158/1541-7786.MCR-07-2110
|
[21]
|
Mazan-Mamczarz, K., Hagner, P.R., Dai, B., et al. (2008) Identification of Transformation-Related Pathways in a Breast Epithelial Cell Model Using a Ribonomics Approach. Cancer Research, 68, 7730-7735.
https://doi.org/10.1158/0008-5472.CAN-08-2393
|
[22]
|
Calaluce, R., Gubin, M.M., Davis, J.W., et al. (2010) The RNA Binding Protein HuR Differentially Regulates Unique Subsets of mRNAs in Estrogen Receptor Negative and Es-trogen Receptor Positive Breast Cancer. BMC Cancer, 10, Article No. 126. https://doi.org/10.1186/1471-2407-10-126
|
[23]
|
Gubin, M.M., Calaluce, R., Davis, J.W., et al. (2010) Overex-pression of the RNA Binding Protein HuR Impairs Tumor Growth in Triple Negative Breast Cancer Associated with Deficient Angiogenesis. Cell Cycle, 9, 3337-3346.
https://doi.org/10.4161/cc.9.16.12711
|
[24]
|
Muralidharan, R., Mehta, M., Ahmed, R., et al. (2017) HuR-Targeted Small Molecule Inhibitor Exhibits Cytotoxicity towards Human Lung Cancer Cells. Scientific Reports, 7, Article No. 9694.
https://doi.org/10.1038/s41598-017-07787-4
|
[25]
|
Kakuguchi, W., Nomura, T., Kitamura, T., et al. (2018) Suramin, Screened from an Approved Drug Library, Inhibits HuR Functions and Attenuates Malignant Phenotype of Oral Cancer Cells. Cancer Medicine, 7, 6269-6280.
https://doi.org/10.1002/cam4.1877
|
[26]
|
Meisner, N.C., Hintersteiner, M., Mueller, K., et al. (2007) Identification and Mechanistic Characterization of Low-Molecular-Weight Inhibitors for HuR. Nature Chemical Biology, 3, 508-515.
https://doi.org/10.1038/nchembio.2007.14
|
[27]
|
Paronetto, M.P., Cappellari, M., Busà, R., et al. (2010) Alternative Splicing of the Cyclin D1 Proto-Oncogene Is Regulated by the RNA-Binding Protein Sam68. Cancer Research, 70, 229-239.
https://doi.org/10.1158/0008-5472.CAN-09-2788
|
[28]
|
Chawla, G., Lin, C.H., Han, A., Shiue, L., Ares, M. and Black, D.L. (2009) Sam68 Regulates a Set of Alternatively Spliced Exons during Neurogenesis. Molecular and Cellular Biology, 29, 201-213.
https://doi.org/10.1128/MCB.01349-08
|
[29]
|
Pérez-Pérez, A., Sánchez-Jiménez, F., Vilariño-García, T., de la Cruz, L., Virizuela, J.A. and Sánchez-Margalet, V. (2016) Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells. PLOS ONE, 11, e0158218. https://doi.org/10.1371/journal.pone.0158218
|
[30]
|
Coolican, S.A., Samuel, D.S., Ewton, D.Z., McWade, F.J. and Florini, J.R. (1997) The Mitogenic and Myogenic Actions of Insulin-Like Growth Factors Utilize Distinct Signaling Pathways. Journal of Biological Chemistry, 272, 6653-6662.
https://doi.org/10.1074/jbc.272.10.6653
|
[31]
|
Vivanco, I. and Sawyers, C.L. (2002) The Phosphatidylinositol 3-Kinase AKT Pathway in Human Cancer. Nature Reviews Cancer, 2, 489-501. https://doi.org/10.1038/nrc839
|
[32]
|
Benoit, Y.D., Mitchell, R.R., Risueño, R.M., et al. (2017) Sam68 Allows Se-lective Targeting of Human Cancer Stem Cells. Cell Chemical Biology, 24, 833-844.e9. https://doi.org/10.1016/j.chembiol.2017.05.026
|
[33]
|
Song, L., Wang, L., Li, Y., et al. (2010) Sam68 Up-Regulation Correlates with, and Its Down-Regulation Inhibits, Proliferation and Tumourigenicity of Breast Cancer Cells. The Journal of Pathology, 222, 227-237.
https://doi.org/10.1002/path.2751
|
[34]
|
Shu, L., Yan, W. and Chen, X. (2006) RNPC1, an RNA-Binding Protein and a Target of the p53 Family, Is Required for Maintaining the Stability of the Basal and Stress-Induced p21 Transcript. Genes and Development, 20, 2961-2972.
https://doi.org/10.1101/gad.1463306
|
[35]
|
Yin, T., Cho, S.J. and Chen, X. (2013) RNPC1, an RNA-Binding Pro-tein and a p53 Target, Regulates Macrophage Inhibitory Cytokine-1 (MIC-1) Expression through mRNA Stability. Journal of Biological Chemistry, 288, 23680-23686.
https://doi.org/10.1074/jbc.M113.480186
|
[36]
|
Cho, S.J., Jung, Y.S., Zhang, J., et al. (2012) The RNA-Binding Protein RNPC1 Stabilizes the mRNA Encoding the RNA-Binding Protein HuR and Cooperates with HuR to Suppress Cell Proliferation. Journal of Biological Chemistry, 287, 14535-14544. https://doi.org/10.1074/jbc.M111.326827
|
[37]
|
Xue, J.Q., Xia, T.S., Liang, X.Q., et al. (2014) RNA-Binding Pro-tein RNPC1: Acting as a Tumor Suppressor in Breast Cancer. BMC Cancer, 14, Article No. 322. https://doi.org/10.1186/1471-2407-14-322
|
[38]
|
Li, X.X., Shi, L., Zhou, X.J., et al. (2017) The Role of c-Myc-RBM38 Loop in the Growth Suppression in Breast Cancer. Journal of Experimental & Clinical Cancer Research, 36, 49. https://doi.org/10.1186/s13046-017-0521-5
|
[39]
|
She, X., Lin, Y., Liang, R., et al. (2020) RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer. OncoTargets and Therapy, 13, 13225-13236. https://doi.org/10.2147/OTT.S278755
|
[40]
|
Zhu, L., Sun, X., Xi, P.W., et al. (2018) Relationship between Expression of RBM38 and Distant Metastasis and Prognosis of Breast Cancer. Chinese Journal of Oncology, 40, 600-603.
|
[41]
|
Moss, E.G. and Tang, L. (2003) Conservation of the Heterochronic Regulator Lin-28, Its Developmental Expression and microRNA Complementary Sites. Developmental Biology, 258, 432-442.
https://doi.org/10.1016/S0012-1606(03)00126-X
|
[42]
|
Piskounova, E., Viswanathan, S.R., Janas, M., et al. (2008) Determinants of microRNA Processing Inhibition by the Developmentally Regulated RNA-Binding Protein Lin28. Journal of Biological Chemistry, 283, 21310-21314.
https://doi.org/10.1074/jbc.C800108200
|
[43]
|
Xiong, H., Zhao, W., Wang, J., et al. (2017) Oncogenic Mechanisms of Lin28 in Breast Cancer: New Functions and Therapeutic Opportunities. Oncotarget, 8, 25721-25735. https://doi.org/10.18632/oncotarget.14891
|
[44]
|
Farzaneh, M., Attari, F. and Khoshnam, S.E. (2017) Concise Re-view: LIN28/let-7 Signaling, a Critical Double-Negative Feedback Loop during Pluripotency, Reprogramming, and Tumorigenicity. Cellular Reprogramming, 19, 289-293.
https://doi.org/10.1089/cell.2017.0015
|
[45]
|
Heo, I., Joo, C., Cho, J., et al. (2008) Lin28 Mediates the Terminal Uridylation of Let-7 Precursor MicroRNA. Molecular Cell, 32, 276-284. https://doi.org/10.1016/j.molcel.2008.09.014
|
[46]
|
Goebel, G.L., Hohnen, L., Borgelt, L., et al. (2022) Small Molecules with Tetrahydroquinoline-Containing Povarov Scaffolds as Inhibitors Disrupting the Protein-RNA Interaction of LIN28-let-7. European Journal of Medicinal Chemistry, 228, Article ID: 114014. https://doi.org/10.1016/j.ejmech.2021.114014
|
[47]
|
Borgelt, L., Li, F., Hommen, P., et al. (2021) Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein-RNA Interaction of LIN28 and Let-7. ACS Medicinal Chemistry Letters, 12, 893-898.
https://doi.org/10.1021/acsmedchemlett.0c00546
|
[48]
|
Xu, C., Jin, S. and Huang, L. (2019) Expression of Lin28 Is Correlated with Prognosis and Expression of HER-2 and Steroid Receptors in Breast Cancer. OncoTargets and Therapy, 12, 1105-1110. https://doi.org/10.2147/OTT.S190328
|